0001104659-22-007952.txt : 20220126
0001104659-22-007952.hdr.sgml : 20220126
20220126215015
ACCESSION NUMBER: 0001104659-22-007952
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220124
FILED AS OF DATE: 20220126
DATE AS OF CHANGE: 20220126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murphy-Chutorian Douglas
CENTRAL INDEX KEY: 0001594342
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36305
FILM NUMBER: 22559715
MAIL ADDRESS:
STREET 1: C/O SEMLER SCIENTIFIC, INC.
STREET 2: 911 BERN COURT, SUITE 110
CITY: SAN JOSE
STATE: CA
ZIP: 95112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Semler Scientific, Inc.
CENTRAL INDEX KEY: 0001554859
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 261367393
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2340-2348 WALSH AVENUE, SUITE 2344
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
BUSINESS PHONE: 408-627-4557
MAIL ADDRESS:
STREET 1: 2340-2348 WALSH AVENUE, SUITE 2344
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
4
1
tm224500d5_4.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-24
0
0001554859
Semler Scientific, Inc.
SMLR
0001594342
Murphy-Chutorian Douglas
C/O SEMLER SCIENTIFIC, INC.
2340-2348 WALSH AVENUE, SUITE 2344
SANTA CLARA
CA
95051
1
1
1
0
Chief Executive Officer
Common Stock
2022-01-24
4
M
0
2000
2.10
A
2000
D
Common Stock
2022-01-24
4
S
0
661
71.2097
D
1339
D
Common Stock
2022-01-24
4
S
0
696
72.0557
D
643
D
Common Stock
2022-01-24
4
S
0
188
73.0822
D
455
D
Common Stock
2022-01-24
4
S
0
355
73.9356
D
100
D
Common Stock
2022-01-24
4
S
0
100
74.89
D
0
D
Stock Option (right to buy)
2.10
2022-01-24
4
M
0
2000
0
D
2024-11-08
Common Stock
2000
81000
D
Shares sold pursuant to a 10b5-1 trading plan adopted by the reporting person on December 7, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.63 to $71.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.695 to $72.465, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.70 to $73.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.73 to $74.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.
The shares underlying the option are fully vested and immediately exercisable.
/s/ Daniel E. Conger, Attorney-in-fact
2022-01-26